our products
our products

Call us at:



Click here to send us an email

Diagnostic Automation Question & AnswerDiagnostic Automation Question & Answer Diagnostic Automation Articles Diagnostic Automation videos

Rapid Ecstasy (MDMA) Drug test (Strip)


MDMA(Ecstasy) (Rapid Test (Strip) RapiDip� InstaTest

Category Name Drug Tests
Test Bulk Or Boxed in 25 or 50 tests
Sensitivity 500 ng/ml

Item #:                    121033-1-21   Quantity:               

Rapid Ecstasy (MDMA) Drug test (Strip)

Rapid Ecstasy (MDMA) Drug test (Strip)

callback phone number email us

Rapid Ecstasy (MDMA) Drug test (Strip) description:

The Ecstasy Drug Test, (MDMA Drug Test) or The Cortez Diagnostics, Inc. DOA (Drug of Abuse) test, is an immunochromatography based one step in vitro test. The Ecstasy drug test is designed for qualitative determination of Ecstasy drug substances in human urine specimen. This assay may be used in the point of care setting.

MDMA Methylenedioxymethamphetamine (Ecstasy) is a designer drug first synthesized in 1914 by a German drug company for the treatment of obesity. Those who take the Ecstasy drug frequently report adverse effects, such as increased muscle tension and sweating. The Ecstasy drug is not clearly a stimulant, although it has, in common with amphetamine drugs, a capacity to increase blood pressure and heart rate. The Ecstasy drug does produce some perceptual changes in the form of increased sensitivity to light, difficulty in focusing, and blurred vision in some users. Its mechanism of action is thought to be via release of the neurotransmitter serotonin. The Ecstasy drug may also release dopamine, although the general opinion is that this is a secondary effect of the drug. The most pervasive effect of the Ecstasy drug, occurring in almost all people who have taken a reasonable dose of the Ecstasy drug, is to produce a clenching of the jaws.

The Ecstasy Drug Testing device is based on the principle of specific immunochemical reaction between antibodies and antigens to analyze particular compounds in human urine specimen. The assay relies on the competition for binding antibody between drug conjugate and free drug which may be present in the urine specimen being tested.  When the Ecstasy drug is present in the urine specimen, it competes with drug conjugate for the limited amount of antibody-dye conjugate. When the amount of the Ecstasy drug is equal or more than the cut-off, it will prevent the binding of drug conjugate to the antibody. Therefore, a positive urine specimen on the Ecstasy drug test will not show a colored band on the test line zone, indicating a positive result, while the presence of a colored band indicates a negative result. A control line is present in the test window to work as procedural control. This colored band should always appear on the control line zone if the Ecstasy drug test device is stored in good condition and the Ecstasy drug test is performed appropriately.

This Ecstasy Drug Test (MDMA Drug Test) provides only a preliminary analytical test result. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/ mass spectrometry (GC/MS) has been established as the preferred confirmatory method by the Substance Abuse Mental Health Services Administration (SAMHSA). Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.

The optional built-in Adulteration Test is for validation of urine specimen’s integrity and must not be used for In Vitro diagnostic use.  The cutoff level for this Ecstasy Drug Test (MDMA Drug Test) is 500 ng/ml of MDMA.   For customized cutoff level Ecstasy drug tests, please contact Customer Service.  This Ecstasy Drug Test (MDMA Drug Test) is available in multi-panel, cassette, strip, or cup format.